Ourania Tatsis insider trades

Open-market stock purchases and sales by Ourania Tatsis, EVP, Chief Reg. & Quality Off. at Vertex Pharmaceuticals Inc / MA, from SEC Form 4 filings since Oct 1, 2019.

Recent trades

DateStockTradeValue
Jul 21, 2026VRTX Vertex Pharmaceuticals Inc / MABought (not open market)—
Jul 2, 2026VRTX Vertex Pharmaceuticals Inc / MASold$787K
May 7, 2026ODTX Odyssey Therapeutics, IncBought (not open market)—
Feb 25, 2026VRTX Vertex Pharmaceuticals Inc / MASold$126K
Feb 24, 2026VRTX Vertex Pharmaceuticals Inc / MASold (not open market)$789K
Feb 18, 2026VRTX Vertex Pharmaceuticals Inc / MASold$174K
Feb 17, 2026VRTX Vertex Pharmaceuticals Inc / MABought (not open market)—
Feb 17, 2026VRTX Vertex Pharmaceuticals Inc / MASold (not open market)$1.1M
Feb 17, 2026VRTX Vertex Pharmaceuticals Inc / MASold$298K
Feb 13, 2026VRTX Vertex Pharmaceuticals Inc / MASold (not open market)$1.9M
Feb 13, 2026VRTX Vertex Pharmaceuticals Inc / MASold$750K
Feb 11, 2026VRTX Vertex Pharmaceuticals Inc / MASold$215K
Feb 10, 2026VRTX Vertex Pharmaceuticals Inc / MASold (not open market)$1M
Jan 22, 2026VRTX Vertex Pharmaceuticals Inc / MABought (not open market)—
Jan 22, 2026VRTX Vertex Pharmaceuticals Inc / MABought (not open market)—
Jan 7, 2026VRTX Vertex Pharmaceuticals Inc / MASold$2.1M
Dec 3, 2025VRTX Vertex Pharmaceuticals Inc / MASold$2M

Companies traded

  • VRTX Vertex Pharmaceuticals Inc / MA: 89 sales, last Jul 21, 2026
  • ODTX Odyssey Therapeutics, Inc: other filings, last May 7, 2026
  • VERV Verve Therapeutics, Inc: other filings, last Jul 25, 2025

Get free alerts when Ourania Tatsis files a new trade →